Phase 2 Insulin Clinical Trials
15 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–15 of 15 trials
Recruiting
Phase 2
Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance
Partial LipodystrophyInsulin Receptor Mutation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)25 enrolled1 locationNCT05470504
Recruiting
Phase 2
18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism
Congenital Hyperinsulinism
Miguel Pampaloni50 enrolled1 locationNCT04205604
Recruiting
Phase 2Phase 3
Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers
PharmacokineticsPharmacodynamicsInsulin Aspart
Amphastar Pharmaceuticals, Inc.60 enrolled1 locationNCT07560150
Recruiting
Phase 2
Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT)
Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
University Hospital Schleswig-Holstein390 enrolled2 locationsNCT07286747
Recruiting
Phase 2
MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity
Insulin ResistancePrediabetesOverweight/Obesity
Hudson Biotech120 enrolled1 locationNCT07505745
Recruiting
Phase 2
Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
InsulinType 1 Diabetes (T1D)Glycemic Control for Diabetes Mellitus+2 more
University of Virginia40 enrolled1 locationNCT07186660
Recruiting
Phase 2
The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation
Type 1 DiabetesInsulin SensitivityChronic Inflammation
Asger Lund, MD26 enrolled1 locationNCT07247734
Recruiting
Phase 2
Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism
Hyperinsulinism
Washington University School of Medicine100 enrolled1 locationNCT05088798
Recruiting
Phase 2
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
Diabetes MellitusInsulin Sensitivity/ResistanceCardiovascular Diseases+4 more
University of Alabama at Birmingham200 enrolled1 locationNCT04055428
Recruiting
Phase 2
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
Insulin ResistanceChronic Kidney DiseasesFatigue+4 more
University of California, Davis80 enrolled2 locationsNCT04984226
Recruiting
Phase 2
HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
Congenital Hyperinsulinism
Hanmi Pharmaceutical Company Limited16 enrolled7 locationsNCT04732416
Recruiting
Phase 1Phase 2
Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopause
Insulin Resistance Syndrome
Cairo University40 enrolled1 locationNCT06806345
Recruiting
Phase 2
Acupuncture or Metformin for Insulin Resistance in Women With PCOS
Insulin ResistancePolycystic Ovary SyndromeHyperandrogenism
Karolinska Institutet303 enrolled2 locationsNCT02647827
Completed
Phase 2
Investigating the effect of a soluble seaweed dietary fibre on gut, metabolic and skin health.
Keratoderma/psoriatic skin conditionIncreased Chronic InflammationImpaired Glucose Tolerance and Insulin resistance+2 more
University of Wollongong80 enrolled1 locationACTRN12617001010381
Completed
Phase 2Phase 3
CF-IDEA (Cystic Fibrosis - Insulin Deficiency, Early Action): Randomised controlled trial of once-daily insulin detemir in patients with cystic fibrosis and early insulin deficiency
Insulin DeficiencyCystic Fibrosis
Sydney Children's Hospital100 enrolled1 locationACTRN12611000068965